4
Changes in Ownership
FENNEC PHARMACEUTICALS INC. Filed Acc 0001589776-26-000006
Director sold 20,000 shares at $12.00 ($240,000)
- Director acquired 20,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Brughera Marco Maria · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-13 | Exercise or conversion : show line 1 in the form 10b5-1 | +20,000 | $2.11 | $42,200 | 20,000 | D |
| 2026-11-13 | Sale : show line 2 in the form 10b5-1 | −20,000 | $12.00 | $240,000 | 0 | D |
| Open-market sales · 20,000 sh · avg $12.00 · $240,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-11-13 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option | −20,000 | 200,000 | D |
Loading xslF345X06/form4-11162026_041102.xml…